Skip to main content

Pharmaceutical Excipients Market to Witness 6.8% CAGR by 2031 | SkyQuest Technology

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pharmaceutical Excipients Market size was valued at USD 10.12 billion in 2023 to USD 17.13 billion by 2031, growing at a CAGR of 6.8% in the forecast period (2024-2031).

Westford, USA, Sept. 26, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that Pharmaceutical Excipients Market will attain the value of USD 17.13 Billion by 2031, with a CAGR of 6.8% during the forecast period (2024-2031). The increasing prevalence of chronic lifestyle diseases across the globe, coupled with huge investments by pharmaceutical companies in biopharmaceuticals, is expected to significantly impact the growth of the global market during the forecast period. Furthermore, the company is expected to have widespread adoption of pharmaceuticals in many developing countries promising expansion opportunities over time. 

Browse in-depth TOC on ” Pharmaceutical Excipients Market ”   

  • Pages – 242 
  • Tables – 126 
  • Figures – 77 

Explore Comprehensive Insights into The Global Pharmaceutical Excipients Market with A Detailed Sample Report: https://www.skyquestt.com/sample-request/pharmaceutical-excipients-market

Pharmaceutical Excipients Market Overview:  

Report Coverage  Details  
Market Revenue in 2023  USD 10.12 Billion  
Estimated Value by 2031  USD 17.13 Billion 
Growth Rate  Poised to grow at a CAGR of 6.8%  
Forecast Period  2024–2031  
Forecast Units  Value (USD Billion)  
Report Coverage  Revenue Forecast, Competitive Landscape, Growth Factors, and Trends  
Segments Covered  Product, Functionality, Formulation, Functionality Application and Region  
Geographies Covered  North America, Europe, Asia Pacific, and the Rest of the world  
Report Highlights  Updated financial information / product portfolio of players  
Key Market Opportunities  Rising Demand for Pharmaceutical and Biopharmaceutical Medications 
Key Market Drivers  Increase in Excipient Demand  

Pharmaceutical Excipients Market Segmental Analysis

Global Pharmaceutical Excipients Market is segmented on the basis of product, formulation, functionality, functionality application, and region.

By product, market is segmented into organic chemicals, inorganic chemicals, other chemicals.

By functionality, market is segmented into fillers & diluents, suspending & viscosity agents, coating agents, binders, flavoring agents & sweeteners, disintegrants, colorants, lubricants & glidants, preservatives, emulsifying agents, other functionalities.

By functionality application, market is segmented into stabilizers, taste masking, modified release, solubility & bioavailability enhancement, other functionality applications.

By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Oral Pharmaceuticals Segment to Dominate Due to Increase Productivity 

In 2023, oral pharmaceuticals held the largest market share and dominated the market. The most popular route of administration is oral medication, which expands the area at the time of administration. Pharmaceutical industries are dominating the market due to increase productivity. The expansion of oral and pharmaceutical formulations is characterized by revolutionary dosage forms and permanent feeder formulations. 

Ask for Free Customization: https://www.skyquestt.com/speak-with-analyst/pharmaceutical-excipients-market

Fillers and Diluents Segment to Drive Market Due to Widespread Use of Low-cost Treatments 

The fillers and diluents segment are expected to exhibit the highest CAGR during the forecast period. Oral medicines improve the chemical and physical stability of the medicines and give the manufacturer an advantage in terms of packaging and transportation. The industry is growing due to widespread use of low-cost treatments. Diluents and fillers are used to increase and modify the weight of the oral solid dosage form and reduce errors in weight conversion. Various applications of excipients such as high compressibility, dosage accuracy, and maintenance of viscous materials flow characteristics are driving the global market expansion especially chewable tablets for children of mannitol are constantly being produced.  

North America is Growing Due to Increase in R&D Investment 

North America currently holds the largest market share for pharmaceutical excipients and is likely to continue through a similar trend during the forecast period. Key players in industry and technological advancement, increase in R&D investment is expected to drive market growth. The growth of the market is also accelerated by the introduction of technologically advanced or high-quality consumer products. For example, Lubrizol Life Science (LLS) Health, one of the world leaders in rapid growth and innovation in clinical research, introduced Episolec in May 2022. Thus, the aforementioned factors are expected to support the market expansion in the North America region. 

Drivers  

  • Increasing Demand for Functionality Excipients 
  • Patents Expiries Driving Demand for Pharmaceutical Excipients 
  • Rapid Advancements in Nanotechnology 

Restraints  

  • Lack of Proper Approval Process 
  • Adverse Reactions of Excipients 
  • Contamination in Formulations 

Take Action Now: Secure Your Pharmaceutical Excipients Market Today – https://www.skyquestt.com/buy-now/pharmaceutical-excipients-market

Prominent Players in Pharmaceutical Excipients Market   

  • BASF SE (Germany)
  • Ashland Inc. (US)
  • Evonik Industries AG (Germany)
  • Kerry Group PLC (Ireland)
  • Roquette Frères (France)
  • Merck KGaA (Germany)
  • Associated British Foods PLC (UK)
  • ADM (US)
  • Wacker Chemie AG (Germany)
  • Air Liquide (France)
  • Dow (US)
  • Lubrizol Corporation (Berkshire Hathaway) (US)
  • Colorcon (US)
  • DFE Pharma (Germany)
  • Innophos (US)
  • J. Rettenmaier & Söhne GmbH + Co KG (Germany)
  • Actylis (US)
  • Meggle GmbH & Co. KG (Germany)
  • Fuji Chemical Industries Co., Ltd. (Japan)
  • Corel Pharma Chem (India)
  • Biogrund GmbH (Germany)
  • Nitika Pharmaceutical Specialties Pvt. Ltd. (India)
  • R.T. Vanderbilt Holding Company, Inc. (US)
  • Beneo (Germany)

Key Questions Answered in Pharmaceutical Excipients Market Report  

  • How big is the global Pharmaceutical Excipients Market?  
  • What are the key restraints of the global Pharmaceutical Excipients Market size?  
  • Which is the dominating region in the global Pharmaceutical Excipients Market? 

This report provides the following insights:  

Analysis of key drivers (increasing demand for functionality excipients, recent patents expiries driving the demand for pharmaceutical excipients), restraints (h adverse reactions of excipients, contamination in formulations), opportunities (rising demand for pharmaceutical and biopharmaceutical medications) influencing the growth of Pharmaceutical Excipients Market.  

  • Market Dynamics: Comprehensive information about the various products offered by the dominant players in the Pharmaceutical Excipients Market.  
  • Product Development/Innovation: An overview of emerging trends, R&D activities and product launches in the Pharmaceutical Excipients Market.   
  • Market Growth: Detailed information on profitable growing industries.   
  • Market Trends: Complete information about new products, emerging geographical areas and recent developments in the market.  
  • Competitive Analysis: An in-depth analysis of the market segments, growth strategies, revenue analysis, and products of the key market players.  

Read Full Report Here – https://www.skyquestt.com/report/pharmaceutical-excipients-market

Related Reports:  

Excipients Market is growing at a CAGR of 6% in the forecast period (2024-2031)

Sustained Release Excipients Market is growing at a CAGR of 8.4% in the forecast period (2024-2031)

Biopharmaceuticals Contract Manufacturing Market is growing at a CAGR of 5.2% in the forecast period (2024-2031)

Healthcare Electronic Data Interchange Market is growing at a CAGR of 9.6% in the forecast period (2024-2031)

Sterile Tubing Welder Market is growing at a CAGR of 5.8% in the forecast period (2024-2031)

About Us:  

SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.  

We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.  

Contact Us:  

Mr. Jagraj Singh  

Skyquest Technology  

1 Apache Way,  

Westford,  

Massachusetts 01886  

USA (+1) 351-333-4748  

Email: sales@skyquestt.com  

Visit Our Website: https://www.skyquestt.com/ 

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.